Schonfeld Strategic Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $1.08 Million - $1.38 Million	79,756 Added 28.53%	359,267 $5.65 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $471,237 - $770,945	46,611 Added 20.01%	279,511 $4.51 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $74,099 - $92,059	5,947 Added 2.62%	232,900 $2.96 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $269,384 - $323,748	-20,285 Reduced 8.2%	226,953 $3.2 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $762,510 - $1.18 Million	53,472 Added 27.6%	247,238 $3.82 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $336,040 - $430,856	22,629 Added 13.22%	193,766 $3.18 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $2.12 Million - $3.46 Million	171,137 New	171,137 $3.17 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $102,363 - $165,539	-14,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $615,538 - $2.97 Million	-79,940 Reduced 84.29%	14,900 $145,000
Q3 2021 Nov 16, 2021	BUY	$26.46 - $37.15 $1.49 Million - $2.09 Million	56,369 Added 146.52%	94,840 $3.22 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $372,303 - $545,431	11,375 Added 41.98%	38,471 $1.41 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $190,923 - $268,162	-4,727 Reduced 14.85%	27,096 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $55,756 - $71,275	-1,077 Reduced 3.27%	31,823 $1.82 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $536,155 - $711,936	12,241 Added 59.25%	32,900 $2,000
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $765,415 - $1.34 Million	20,659 New	20,659 $1.23 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $987,746 - $2.04 Million	-29,371 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $931,060 - $2.05 Million	29,371 New	29,371 $1.83 Million
Q2 2018 Aug 14, 2018	SELL	$20.06 - $44.95 $604,728 - $1.36 Million	-30,146 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $303,525 - $449,987	15,146 Added 100.97%	30,146 $604,000
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $578,900 - $847,000	-35,000 Reduced 70.0%	15,000 $340,000
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $882,499 - $949,499	50,000	50,000 $950,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account